Company news
Opthea Limited (ASX:OPT) news
Opthea Limited news releases on 6ix. Latest, Aug 29, 2016: Appendix 4E and Annual Report 2016
Press releases — page 4
Appendix 4E and Annual Report 2016
August 29, 2016
Opthea reports positive data from Phase 1 wet AMD Trial
July 25, 2016
Opthea Doses First Patient in Ph2A for OPT-302 in Wet AMD
May 4, 2016
Opthea Ph1 wAMD Trial with OPT-302 Meets Primary Objective
April 20, 2016
Circadian Capital Raising Prospectus
March 30, 2016
Opthea Completes Patient Enrolment for Phase 1 wet AMD Trial
March 29, 2016
Half Year Report and Accounts
February 25, 2016
Circadian Receives $3M R&D Tax Incentive
February 11, 2016
Circadian Board Changes and Renewal
February 10, 2016